RJA
Raymond James & Associates’s AtriCure ATRC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-6,145
| Closed | -$240K | – | 3784 |
|
|
2022
Q3 | $240K | Sell |
6,145
-11,272
| -65% | -$440K | ﹤0.01% | 3294 |
|
|
2022
Q2 | $712K | Sell |
17,417
-4,768
| -21% | -$195K | ﹤0.01% | 2667 |
|
|
2022
Q1 | $1.46M | Sell |
22,185
-389
| -2% | -$25.5K | ﹤0.01% | 2347 |
|
|
2021
Q4 | $1.57M | Sell |
22,574
-2,197
| -9% | -$153K | ﹤0.01% | 2327 |
|
|
2021
Q3 | $1.72M | Buy |
24,771
+1,401
| +6% | +$97.5K | ﹤0.01% | 2205 |
|
|
2021
Q2 | $1.85M | Buy |
23,370
+5,602
| +32% | +$444K | ﹤0.01% | 2150 |
|
|
2021
Q1 | $1.16M | Buy |
17,768
+2,298
| +15% | +$151K | ﹤0.01% | 2401 |
|
|
2020
Q4 | $861K | Buy |
15,470
+6,734
| +77% | +$375K | ﹤0.01% | 2430 |
|
|
2020
Q3 | $349K | Buy |
+8,736
| New | +$349K | ﹤0.01% | 2845 |
|
|
2017
Q3 | – | Sell |
-30,000
| Closed | -$728K | – | 3263 |
|
|
2017
Q2 | $728K | Hold |
30,000
| – | – | ﹤0.01% | 2212 |
|
|
2017
Q1 | $575K | Hold |
30,000
| – | – | ﹤0.01% | 2290 |
|
|
2016
Q4 | $587K | Hold |
30,000
| – | – | ﹤0.01% | 2234 |
|
|
2016
Q3 | $475K | Hold |
30,000
| – | – | ﹤0.01% | 2317 |
|
|
2016
Q2 | $424K | Hold |
30,000
| – | – | ﹤0.01% | 2189 |
|
|
2016
Q1 | $505K | Hold |
30,000
| – | – | ﹤0.01% | 2033 |
|
|
2015
Q4 | $673K | Sell |
30,000
-9,193
| -23% | -$206K | ﹤0.01% | 1834 |
|
|
2015
Q3 | $859K | Buy |
39,193
+9,193
| +31% | +$201K | ﹤0.01% | 1670 |
|
|
2015
Q2 | $739K | Hold |
30,000
| – | – | ﹤0.01% | 1866 |
|
|
2015
Q1 | $615K | Hold |
30,000
| – | – | ﹤0.01% | 1933 |
|
|
2014
Q4 | $599K | Hold |
30,000
| – | – | ﹤0.01% | 1861 |
|
|
2014
Q3 | $442K | Hold |
30,000
| – | – | ﹤0.01% | 1893 |
|
|
2014
Q2 | $551K | Hold |
30,000
| – | – | ﹤0.01% | 1790 |
|
|
2014
Q1 | $564K | Sell |
30,000
-10,000
| -25% | -$188K | ﹤0.01% | 1731 |
|
|
2013
Q4 | $747K | Hold |
40,000
| – | – | 0.01% | 1473 |
|
|
2013
Q3 | $439K | Hold |
40,000
| – | – | ﹤0.01% | 1642 |
|
|
2013
Q2 | $380K | Buy |
+40,000
| New | +$380K | ﹤0.01% | 1621 |
|